Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial.

Li WQ, Zhang JY, Ma JL, Li ZX, Zhang L, Zhang Y, Guo Y, Zhou T, Li JY, Shen L, Liu WD, Han ZX, Blot WJ, Gail MH, Pan KF, You WC.

BMJ. 2019 Sep 11;366:l5016. doi: 10.1136/bmj.l5016.

2.

Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: A randomized, double-blind, placebo-controlled study.

Yoon JY, Cha JM, Hong SS, Kim HK, Kwak MS, Jeon JW, Shin HP.

Medicine (Baltimore). 2019 Aug;98(35):e16601. doi: 10.1097/MD.0000000000016601.

3.

Multidrug resistance in Helicobacter pylori: current state and future directions.

Boyanova L, Hadzhiyski P, Kandilarov N, Markovska R, Mitov I.

Expert Rev Clin Pharmacol. 2019 Sep;12(9):909-915. doi: 10.1080/17512433.2019.1654858. Epub 2019 Aug 28. Review.

PMID:
31424296
4.

Helicobacter pylori infection and the risk of colorectal carcinoma: a systematic review and meta-analysis.

Yang F, Xu YL, Zhu RF.

Minerva Med. 2019 Oct;110(5):464-470. doi: 10.23736/S0026-4806.19.05942-1.

PMID:
31368293
5.

The important role played by chemokines influence the clinical outcome of Helicobacter pylori infection.

Jafarzadeh A, Nemati M, Jafarzadeh S.

Life Sci. 2019 Aug 15;231:116688. doi: 10.1016/j.lfs.2019.116688. Epub 2019 Jul 23. Review.

PMID:
31348950
6.

Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection.

Kobayashi S, Joshita S, Yamamoto C, Yanagisawa T, Miyazawa T, Miyazawa M, Kubota D, Sato J, Umemura T, Tanaka E.

Medicine (Baltimore). 2019 Jul;98(30):e16619. doi: 10.1097/MD.0000000000016619.

7.

A meta-analysis of the association between the presence of Helicobacter pylori and periodontal diseases.

Chen Z, Cai J, Chen YM, Wei J, Li HB, Lu Y, Zhou Z, Chen XL.

Medicine (Baltimore). 2019 May;98(22):e15922. doi: 10.1097/MD.0000000000015922.

8.

The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers: A retrospective study.

Song WC, Wang XF, Lv WW, Xu XY, Tian M.

Medicine (Baltimore). 2019 May;98(22):e15807. doi: 10.1097/MD.0000000000015807.

9.

Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System.

Hold GL, Hansen R.

Curr Top Microbiol Immunol. 2019;421:303-318. doi: 10.1007/978-3-030-15138-6_12. Review.

PMID:
31123894
10.

Helicobacter pylori Deregulates T and B Cell Signaling to Trigger Immune Evasion.

Reyes VE, Peniche AG.

Curr Top Microbiol Immunol. 2019;421:229-265. doi: 10.1007/978-3-030-15138-6_10. Review.

PMID:
31123892
11.

Carbohydrate-Dependent and Antimicrobial Peptide Defence Mechanisms Against Helicobacter pylori Infections.

Padra M, Benktander J, Robinson K, Lindén SK.

Curr Top Microbiol Immunol. 2019;421:179-207. doi: 10.1007/978-3-030-15138-6_8. Review.

PMID:
31123890
12.

Role of NOD1 and ALPK1/TIFA Signalling in Innate Immunity Against Helicobacter pylori Infection.

Ying L, Ferrero RL.

Curr Top Microbiol Immunol. 2019;421:159-177. doi: 10.1007/978-3-030-15138-6_7. Review.

PMID:
31123889
13.

Importance of Toll-like Receptors in Pro-inflammatory and Anti-inflammatory Responses by Helicobacter pylori Infection.

Nagashima H, Yamaoka Y.

Curr Top Microbiol Immunol. 2019;421:139-158. doi: 10.1007/978-3-030-15138-6_6. Review.

PMID:
31123888
14.

Impact of Helicobacter pylori Virulence Factors on the Host Immune Response and Gastric Pathology.

Javed S, Skoog EC, Solnick JV.

Curr Top Microbiol Immunol. 2019;421:21-52. doi: 10.1007/978-3-030-15138-6_2. Review.

PMID:
31123884
15.

Inflammation, Immunity, and Vaccine Development for the Gastric Pathogen Helicobacter pylori.

Ikuse T, Blanchard TG, Czinn SJ.

Curr Top Microbiol Immunol. 2019;421:1-19. doi: 10.1007/978-3-030-15138-6_1. Review.

PMID:
31123883
16.

Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies.

Chen S, Chen L, Tan Y, Wang J.

Medicine (Baltimore). 2019 May;98(18):e15468. doi: 10.1097/MD.0000000000015468.

17.

Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?

Baylina M, Muñoz N, Sánchez-Delgado J, López-Góngora S, Calvet X, Puig I.

Helicobacter. 2019 Jun;24(3):e12584. doi: 10.1111/hel.12584. Epub 2019 Apr 16.

PMID:
30990575
18.

Efficacy and safety of probiotics in eradicating Helicobacter pylori: A network meta-analysis.

Shi X, Zhang J, Mo L, Shi J, Qin M, Huang X.

Medicine (Baltimore). 2019 Apr;98(15):e15180. doi: 10.1097/MD.0000000000015180.

19.

The effect of synbiotics in improving Helicobacter pylori eradication: A systematic review and meta-analysis.

Pourmasoumi M, Najafgholizadeh A, Hadi A, Mansour-Ghanaei F, Joukar F.

Complement Ther Med. 2019 Apr;43:36-43. doi: 10.1016/j.ctim.2019.01.005. Epub 2019 Jan 9.

PMID:
30935552
20.

Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta-analysis of observational studies.

Zhou BG, Yang HJ, Xu W, Wang K, Guo P, Ai YW.

Helicobacter. 2019 Jun;24(3):e12576. doi: 10.1111/hel.12576. Epub 2019 Mar 25.

PMID:
30907050

Supplemental Content

Loading ...
Support Center